Autopsy report · NCT00667017
RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma
Cause of deathSlow enrollment
“Slow accrual.”
Life of this trial
- Registered 6 months before it started.
- Ran for about 1 year 3 months before it stopped.
- 1 participant enrolled.
- Results were posted on the registry 8 years 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Lymphoma
- Interventions
- RFT5-dgA immunotoxin; fluorescence activated cell sorting; immunohistochemistry staining method
- Participants
- 1
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.